To Evaluate Long- Term Safety and Efficacy of Luspatercept

Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

NCT04143724 ·Status: RECRUITING ·Phase: PHASE2

The Safety and Efficiency of Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia: a Real-world Study

NCT05462548 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

NCT05891249 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Clinical Observation of Luspatercept in Treatment of Chinese Adult β-thalassaemia Patients With TD β-thalassemia

NCT06164821 ·Status: RECRUITING ·Phase: NA

A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East

NCT07215975 ·Status: RECRUITING

A Study to Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β)-Thalassemia

NCT03342404 ·Status: COMPLETED ·Phase: PHASE2

A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia

NCT06073860 ·Status: RECRUITING

A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in Taiwan

NCT06596642 ·Status: ACTIVE_NOT_RECRUITING

Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients

NCT07338344 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion

NCT01740531 ·Status: COMPLETED ·Phase: PHASE3

A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection

NCT06717932 ·Status: ENROLLING_BY_INVITATION

Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia

NCT01709838 ·Status: COMPLETED ·Phase: PHASE4

Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload

NCT00564941 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

NCT05577312 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2

Gene Therapy for Transfusion Dependent Beta-thalassemia

NCT02453477 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major

NCT06291961 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients

NCT06219239 ·Status: RECRUITING ·Phase: NA

Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload

NCT00560820 ·Status: COMPLETED ·Phase: PHASE1

Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec

NCT00879242 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study

NCT00873041 ·Status: COMPLETED ·Phase: PHASE2

GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)

NCT05632354 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.

NCT01571635 ·Status: TERMINATED ·Phase: PHASE2

Safety Study for Beta Thalassemia Subjects on PTG-300

NCT04054921 ·Status: COMPLETED ·Phase: PHASE2

Monitoring of Anti-SARS-CoV-2 (COVID 19) and Encapsulated Vaccination Patients With Thalassemic and Falcemic Syndromes

NCT05157256 ·Status: ACTIVE_NOT_RECRUITING

Impact of the Preparation Method of Red Cell Concentrates on Transfusion Indices in Thalassemic Patients

NCT03992001 ·Status: COMPLETED ·Phase: PHASE4